Interdisciplinary Program in Neuroscience Courses

	September 4: Dr. Guinevere Eden Associate Professor, Director of the Center for the Study of Learning Department of Pediatrics A Comparison of the Neuro-developmental Basis of Reading in Two Writing Systems (awarded RO-1)
	September 11: No Class (IPN Retreat) RESCHEDULED for Monday, Nov 30
	September 18th: Dr. Chandan Vaidya Associate Professor of Psychology Neuroimaging of Top-Down Control and Bottom-Up Processes in Childhood ASD (awarded RO-1)
	September 25: Dr. Daniel Pak Assistant Professor of Pharmacology Plk2 as a potential novel target for Alzheimer's Disease therapeutics (RC-1 application submitted this past Spring, which is now being revised for submission as an RO-1 next month)
	October 2: Dr. John VanMeter Assistant Professor of Neurology Director of the Center for Functional and Molecular Imaging Autism Subtyping Using Genomic, Metabolomic, and Neuroimaging Data application for an R21 ('exploratory/developmental research grant') that was submitted for a special NIH stimulus package RFA this past spring (not funded) and which is being rewritten for a new submission.
	October 9: Dr. Kathleen Maguire Zeiss Associate Professor of Neuroscience Toxicant, oxidative injury, dopamine & synuclein in Parkinson's Disease (awarded RO-1)
	October 16: Dr. Karen Gale and Patrick Forcelli Professor of Pharmacology and thesis student Striatal Sequelae of Perinatal Anticonvulsant Drug Treatment (NRSA predoctoral fellowship application-- funded on the first submission)
	October 23 2:30-4:30PM (NOTE SPECIAL TIME): Dr. Stefano Vicini Professor of Physiology & Biophysics GABA channels and dopamine in the striatum (RO-1 application that has been resubmitted once and will be resubmitted for a second time--i.e. an A2 application-- in November)
	October 30: Dr. Howard Federoff Executive Vice President of Health Sciences and Executive Dean of the Medical School Developing a scaleable model for Parkinson's disease (reviewed, funding status pending) This is a RC2 or " Grand Opportunities" --aka "GO" grant Under the Recovery Act, the NIH has established a new program entitled Research and Research Infrastructure “Grand Opportunities”(RFA-OD-09-004) hereafter called the ”GO” grants program.This new program will support projects that address large, specific biomedical and biobehavioral research endeavors that will benefit from significant 2-year funds without the expectation of continued NIH funding beyond 2 years. The research should have high short-term impact, and a high likelihood of enabling growth and investment in biomedical research and development, public health, and health care delivery.
	November 6: Dr. Maria Donoghue Assistant Professor of Biology Control of Cerebral Cortical Proliferation (grant funded by NSF)
	November 13: Dr. Bill Rebeck Professor of Neuroscience Trafficking, shedding, and functions of ApoER2 This is one of 5 projects in an NIH multi-site program project grant (a PO1 award). The program project is composed of 5 different projects from 5 separate institutions. The grant was awarded this year after 3 submissions (an initial submission and two revisions). This success is the result of the continued efforts of the program project team of investigators over a 4 year period.
	November 20: Italo Mocchetti Professor of Neuroscience HIV drug abusers, polymorphisms and brain plasticity Current RO1 and a review article on this topic.
	November 27: Dr. Ima Turkey Assistant Professor, Department of Farm Ecology The effects of cranberry sauce on the absorption of avian proteins
	MONDAY November 30 (note special date): Dr. Hyang Sook Hoe Assistant Professor of Neurology ApoE and ApoE receptors in the molecular mechanisms of synapse formation (NIH funded RO3 grant, aka "small grant")
	December 4: Dr. Baoji Xu Associate Professor of Pharmacology Dysregulation of local BDNF synthesis in fragile X syndrome R21 (Exploratory/Developmental Research Grant Award) funded on the first submission
	December 11: Dr. Scott Turner Professor of Neurology Passive immunization of ApoE targeted replacement in AD tg mice (first submission of a competing renewal application for an RO-1)